Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Secant Group is a commercial-stage company specializing in advanced biomaterials, medical textiles, and implantable components for medical devices. Their proprietary Regenerez® bioresorbable scaffold is used in cardiovascular regenerative medicine applications, and they have ongoing collaborations in advanced cell therapy scaffolds, drug delivery, and tissue engineering. Their products are used in therapeutic areas including cardiovascular, general surgery, orthopedic, and neurovascular indications. The company is known for its expertise in integrating advanced polymers and textile technologies into next-generation medical solutions, and is active in both prototyping and large-scale manufacturing for partners in the medical device and pharmaceutical industries[1][3][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Secant Group.